Skip to main content

Cancer

 

Clinical courses

  • Opening for Ph.D Candidate in Project-Cancer Research in Auckland Cancer Society Research Centre, University of Auckland

    The University of Auckland is Founded in 1883, Auckland is the country’s largest university with over 40,000 students, nearly 10,000 of whom graduate annually. The main campus is in the heart of Auckland city and we have four specialist campuses. The only New Zealand university ranked in the top 200 in the Times Higher Education World University Rankings.

  • The widespread belief that radiations from X-rays and CT scans can cause cancer has flaws and is based on an unproven theoretical model, suggests a study.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • Due to dietary factors, humans are taller now but taller people are more prone to the risk of cancer, warns a recent study.The taller people, though have lower risk for heart disease and Type-2 diabetes, said the study carried out by researchers in Germany.

  • U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma. This indication is approved under accelerated approval based on progression-free survival (PFS). Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

  • Genmab announced  that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for the use of Arzerra® (ofatumumab) for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive chronic lymphocytic leukemia (CLL).  The application was submitted by Novartis under the ofatumumab collaboration between the two companies.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • Application Invited for the Post of Junior Research Fellow in M. D. University

    Maharshi Dayanand University, ab initio established as Rohtak University, Rohtak, came into existence by an Act No. 25 of 1975 of the Haryana Legislative Assembly in 1976  with the objective to promote inter-disciplinary higher education and research in the fields of environmental, ecological and life sciences. It was rechristened as Maharshi Dayanand University in 1977 after the name of a great visionary and social reformer, Maharshi Dayanand.  It had a unitary and residential character in its nascent stage, but became an affiliating University in November 1978. The University secured the recognition of University Grants Commission – the higher education regulatory body of India - for central Govt. grants in Feb. 1983.

Subscribe to Cancer